Dr. Jennifer H. Mieres, an expert in cardiovascular disease of women and patient-centered health care advocacy, will receive the award at an event June 28 NEW HYDE PARK, NY – Jennifer H. Mieres, MD, senior vice president of Northwell Health’s […]
Tag: AHA
Solstice Supports the American Heart Association’s Broward Heart Walk
Funds raised by Solstice’s Heart Walk team support the lifesaving work of the American Heart Association. PLANTATION, Fla., March 15, 2022 (GLOBE NEWSWIRE) — Solstice sponsored the finish line at the American Heart Association (AHA) Broward Heart Walk on Sunday, […]
Valbiotis Announces Positive Preclinical Results for TOTUM•070 in Hypercholesterolemia, Selected and Presented at the American Heart Association (AHA) Annual Meeting
Two in-depth studies on TOTUM•070 conducted jointly by Valbiotis’ preclinical platform and the University of Leiden (Netherlands), have been selected by the annual meeting of the AHA, the leading American learned society in the cardiovascular field. Results showing a dose-dependent […]
HeartFlow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as an Important Tool in Diagnosing and Treating Heart Disease
Chest Pain Guidelines also elevate coronary CT as the only first-line test for many patients REDWOOD CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today welcomed new clinical practice guidelines from the American College […]
Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have been in the news in recent days
– Genetics allows the study of risk related to hereditary cardiovascular disease, with special relevance in cardiomyopathies, arrhythmias and vascular involvement syndromes that may involve risk of sudden death. – The myCardio service designed by Veritas Intercontinental, a company focused […]
Acceleron Announces Clinical Trial Updates, Preclinical Presentation on Sotatercept in Pulmonary Arterial Hypertension at the 2020 American Heart Association (AHA) Scientific Sessions
– Presentation of cardiac and pulmonary function data from the ongoing PULSAR Phase 2 trial receives AHA’s “Cardiopulmonary Best Abstract” Award – – AHA sessions to include data from the ongoing SPECTRA Phase 2 trial – – Acceleron to host […]
Pulsara Granted AHA Get With the Guidelines® Compatible Vendor Status
BOZEMAN, Mont., July 31, 2020 /PRNewswire/ — Pulsara, the leading telehealth and communication platform that connects teams across organizations, announced today that the company has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA […]
American Heart Association Names Omron Healthcare President & CEO Ranndy Kellogg To Board of Directors
LAKE FOREST, Ill., Oct. 1, 2019 /PRNewswire/ — Today, the American Heart Association (AHA), the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke, announced that it has appointed Ranndy Kellogg, president and CEO of Omron Healthcare, Inc., to […]
Total Brain Joins the American Heart Association’s Center for Health Technology & Innovation to Study Uses of Heart Rate Variability Data to Reduce Stress and Risk of Cardiovascular Incidents
SAN FRANCISCO, June 22, 2019 /PRNewswire/ — Total Brain, a neuroscience-based mental health and fitness platform, is joining the American Heart Association’s Center for Health Technology & Innovation’s (the Center) Innovators Network. The Association’s Center is focused on building and fostering health technologies and relationships […]
Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018
CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Shifa Biomedical Corporation (Shifa), a drug discovery biopharmaceutical company focused on developing novel agents to treat cardiovascular disease and hypercholesteremia, today announced exciting preclinical data involving the company’s pre-clinical candidate, P-21, which interferes […]
Recent
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Popular
- No commented posts yet